OXiGENE, Inc. (NASDAQ: OXGN)
OXiGENE is a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer. The Company's major focus is developing vascular disrupting agents (VDAs) that selectively disrupt abnormal blood vessels associated with solid tumor progression. OXiGENE is dedicated to leveraging its intellectual property and therapeutic development expertise to bring life-extending and life-enhancing medicines to patients.
Company Website: http://www.oxigene.com/
OXiGENE Inc (NASDAQ: OXGN) Stock Message Board
9 | OXGN 1.83 Oxigene Inc Stock Charts $OXGN Last | chartguy89 | 03/06/2015 4:29:47 AM |
8 | OXGN Stock year to date has changed +12.42% | Jake13 | 02/24/2015 6:47:10 AM |
7 | OXGN 1.81 Oxigene Inc Stock Charts $OXGN Last | chartguy89 | 02/24/2015 6:13:23 AM |
6 | Volume Alert - OXGN 2.01 Oxigene Inc $OXGN Hit a | leahanne | 11/17/2014 2:41:47 PM |
5 | Latest Oxigene Inc (OXGN) Headlines SmarTrend | Stock_Tracker | 03/13/2014 12:15:33 PM |
4 | RTI Surgical Inc. (RTIX) A hernia is a condition | riddock57 | 03/12/2014 4:29:14 AM |
3 | OXGN Stock Charts Last: +0.03 Saturday, March 1, | chartguy89 | 03/01/2014 8:54:04 PM |
2 | OXGN Stock Charts Last: +0.08 Friday, February | chartguy89 | 02/28/2014 2:47:03 AM |
1 | OXGN. $3.19 gap off bottom. | PoemStone | 07/20/2013 9:48:04 AM |